You are here:Home-Chemical Inhibitors & Agonists-Antibiotics and Antivirals-Bacterial-DS01750413
DS01750413

Chemical Structure : DS01750413

CAS No.: 2881067-92-9

DS01750413 (DS 01750413)

Catalog No.: PC-47011Not For Human Use, Lab Use Only.

DS01750413 is a novel FtsZ inhibitor and new derivative of PC190723 (Cat. PC-47012), inhibits S. aureus FtsZ protein with IC50 of 2 mg/L, has an IC50 of 0.03 mg/L in cell elongation assay of B. subtilis.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    DS01750413 is a novel FtsZ inhibitor and new derivative of PC190723 (Cat. PC-47012), inhibits S. aureus FtsZ protein with IC50 of 2 mg/L, has an IC50 of 0.03 mg/L in cell elongation assay of B. subtilis.
    DS01750413 shows no acitvity against mammalian tubulin (IC50>200 mg/L) and no any cytotoxicity concern.
    DS01750413 exhibitsa strong inhibitory activity against clinical isolates of S. aureus including MRSA and MSSA with an MIC range of 0.25-2 and 0.125-2 mg/L, respectively.
    DS01750413 also displays a similar activity against other Gram-positive bacteria, including MRSA strains that are resistant to current SOC antibiotics.
    DS01750413 displays a strong synergy specifically in combination with β-lactam antibiotics, but exhibits indifference effect with vancomycin and linezolid.
    DS01750413 shows no activity against G196S or N263S mutants (MIC>32 mg/L).
    DS01750413 (100 and 200 mg/kg, i.p.) showed a dose-dependent efficacy in the neutropenic murine bacteraemia infection model of S. aureus Smith.

    Physicochemical Properties

    M.Wt 488.217
    Formula C18H13BrF3N3O5
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    (R)-5-(1-(5-bromo-4-(4-(trifluoromethoxy)phenyl)oxazol-2-yl)-2-hydroxyethoxy)nicotinamide

    References

    1. Manoj Kumar, et al. J Antimicrob Chemother. 2021 Oct 11;76(11):2867-2874. 

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: